BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27746145)

  • 1. Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential.
    Chen WL; Wang YY; Zhao A; Xia L; Xie G; Su M; Zhao L; Liu J; Qu C; Wei R; Rajani C; Ni Y; Cheng Z; Chen Z; Chen SJ; Jia W
    Cancer Cell; 2016 Nov; 30(5):779-791. PubMed ID: 27746145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma.
    Jin X; Liang Y; Liu D; Luo Q; Cai L; Wu J; Jia L; Chen WL
    Cell Biol Toxicol; 2019 Oct; 35(5):471-483. PubMed ID: 31102011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Zhao P; Huang J; Zhang D; Zhang D; Wang F; Qu Y; Guo T; Qin Y; Wei J; Niu T; Zheng Y
    Br J Haematol; 2018 Oct; 183(2):242-250. PubMed ID: 30272826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia.
    Lai B; Lai Y; Zhang Y; Zhou M; Sheng L; OuYang G
    Technol Cancer Res Treat; 2020; 19():1533033819894308. PubMed ID: 31918632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT5 increases fructose utilization and promotes tumor progression in glioma.
    Su C; Li H; Gao W
    Biochem Biophys Res Commun; 2018 Jun; 500(2):462-469. PubMed ID: 29660339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet-induced epigenetic regulation in vivo of the intestinal fructose transporter Glut5 during development of rat small intestine.
    Suzuki T; Douard V; Mochizuki K; Goda T; Ferraris RP
    Biochem J; 2011 Apr; 435(1):43-53. PubMed ID: 21222652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone sensitizes the neonatal intestine to fructose induction of intestinal fructose transporter (Slc2A5) function.
    Douard V; Cui XL; Soteropoulos P; Ferraris RP
    Endocrinology; 2008 Jan; 149(1):409-23. PubMed ID: 17947353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling.
    Chen WL; Jin X; Wang M; Liu D; Luo Q; Tian H; Cai L; Meng L; Bi R; Wang L; Xie X; Yu G; Li L; Dong C; Cai Q; Jia W; Wei W; Jia L
    JCI Insight; 2020 Feb; 5(3):. PubMed ID: 32051337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid enhances the antileukemic effect of cytarabine by triggering cell apoptosis.
    Liu N; Wang C; Wang L; Gao L; Cheng H; Tang G; Hu X; Wang J
    Int J Mol Med; 2016 Jun; 37(6):1686-96. PubMed ID: 27082972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension.
    Barone S; Fussell SL; Singh AK; Lucas F; Xu J; Kim C; Wu X; Yu Y; Amlal H; Seidler U; Zuo J; Soleimani M
    J Biol Chem; 2009 Feb; 284(8):5056-66. PubMed ID: 19091748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR.
    Zwarts I; van Zutphen T; Kruit JK; Liu W; Oosterveer MH; Verkade HJ; Uhlenhaut NH; Jonker JW
    Sci Rep; 2019 Jun; 9(1):9299. PubMed ID: 31243309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Roles of Glut5 in Imatinib Resistance in the Ph
    Yan TY; Naren DL; Gong YP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):389-393. PubMed ID: 28616912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of essential amino acids for glucose transporter 5 (GLUT5)-mediated fructose transport.
    Ebert K; Ewers M; Bisha I; Sander S; Rasputniac T; Daniel H; Antes I; Witt H
    J Biol Chem; 2018 Feb; 293(6):2115-2124. PubMed ID: 29259131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose utilization enhanced by GLUT5 promotes lung cancer cell migration via activating glycolysis/AKT pathway.
    Yang J; Dong C; Wu J; Liu D; Luo Q; Jin X
    Clin Transl Oncol; 2023 Apr; 25(4):1080-1090. PubMed ID: 36454516
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Weng Y; Fan X; Bai Y; Wang S; Huang H; Yang H; Zhu J; Zhang F
    Cell Death Discov; 2018 Dec; 4():38. PubMed ID: 29531835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-Allulose is a substrate of glucose transporter type 5 (GLUT5) in the small intestine.
    Kishida K; Martinez G; Iida T; Yamada T; Ferraris RP; Toyoda Y
    Food Chem; 2019 Mar; 277():604-608. PubMed ID: 30502192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer.
    Shen Z; Li Z; Liu Y; Li Y; Feng X; Zhan Y; Lin M; Fang C; Fang Y; Deng H
    Cancer Lett; 2022 May; 534():215617. PubMed ID: 35257833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a yeast-based screening system for discovery of human GLUT5 inhibitors and activators.
    Tripp J; Essl C; Iancu CV; Boles E; Choe JY; Oreb M
    Sci Rep; 2017 Jul; 7(1):6197. PubMed ID: 28740135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the Fructose Transporter Gene
    Mizuno TM; Lew PS; Jhanji G
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.